Login
|
New Account
AAAAAA
ITA
ENG
Results:
1-7
|
Results: 7
European Survey on Anaemia Management (ESAM) - Patients and methods
Authors:
Valderrabano, F Horl, WH Jacobs, C Macdougall, IC Parrondo, I Manhaeve, D Milisen, K
Citation:
F. Valderrabano et al., European Survey on Anaemia Management (ESAM) - Patients and methods, NEPH DIAL T, 15, 2000, pp. 2-7
European Best Practice Guidelines 1-4 - Evaluating anaemia and initiating treatment
Authors:
Valderrabano, F Horl, WH Jacobs, C Macdougall, IC Parrondo, I Cremers, S Abraham, IL
Citation:
F. Valderrabano et al., European Best Practice Guidelines 1-4 - Evaluating anaemia and initiating treatment, NEPH DIAL T, 15, 2000, pp. 8-14
European Best Practice Guidelines 5 - Target haemoglobin
Authors:
Jacobs, C Horl, WH Macdougall, IC Valderrabano, F Parrondo, I Segner, A Abraham, IL
Citation:
C. Jacobs et al., European Best Practice Guidelines 5 - Target haemoglobin, NEPH DIAL T, 15, 2000, pp. 15-19
European Best Practice Guidelines 6-8 - Assessing and optimizing iron stores
Authors:
Macdougall, IC Horl, WH Jacobs, C Valderrabano, F Parrondo, I Thompson, K Cremers, S
Citation:
Ic. Macdougall et al., European Best Practice Guidelines 6-8 - Assessing and optimizing iron stores, NEPH DIAL T, 15, 2000, pp. 20-32
European Best Practice Guidelines 9-13 - Anaemia management
Authors:
Jacobs, C Horl, WH Macdougall, IC Valderrabano, F Parrondo, I Abraham, IL Segner, A
Citation:
C. Jacobs et al., European Best Practice Guidelines 9-13 - Anaemia management, NEPH DIAL T, 15, 2000, pp. 33-42
European Best Practice Guidelines 14-16 - Inadequate response to epoetin
Authors:
Horl, WH Jacobs, C Macdougall, IC Valderrabano, F Parrondo, I Thompson, K Carveth, BG
Citation:
Wh. Horl et al., European Best Practice Guidelines 14-16 - Inadequate response to epoetin, NEPH DIAL T, 15, 2000, pp. 43-50
European Best Practice Guidelines 17-18 - Adverse effects
Authors:
Horl, WH Jacobs, C Macdougall, IC Valderrabano, F Parrondo, I Carveth, BG Thompson, K
Citation:
Wh. Horl et al., European Best Practice Guidelines 17-18 - Adverse effects, NEPH DIAL T, 15, 2000, pp. 51-56
Risultati:
1-7
|